批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/10/08 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/02/05 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/02/05 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/02/05 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/03/15 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/03/15 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/03/15 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/03/15 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/10/19 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/05/31 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/09/11 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:ESCITALOPRAM OXALATE 剂型/给药途径:TABLET;ORAL 规格:EQ 5MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021323 |
001 |
NDA |
LEXAPRO |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
Yes |
No |
AB |
2002/08/14
|
ABBVIE |
076765 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Discontinued |
No |
No |
AB |
2012/03/14
|
TEVA PHARMS USA |
077734 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
ZYDUS LIFESCIENCES |
078169 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
CHARTWELL RX |
078604 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
INVAGEN PHARMS |
078777 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
GRAVITI PHARMS |
090432 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
AUROBINDO PHARMA LTD |
090939 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
TORRENT PHARMS LTD |
202210 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
MACLEODS PHARMS LTD |
202389 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
ACCORD HLTHCARE |
202280 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2012/09/12
|
JUBILANT CADISTA |
077512 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Discontinued |
No |
No |
AB |
2012/09/12
|
ANIMA |
078032 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2015/08/28
|
PRINSTON INC |
205619 |
001 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 5MG BASE |
Prescription |
No |
No |
AB |
2017/05/17
|
AMNEAL PHARMS |
活性成分:ESCITALOPRAM OXALATE 剂型/给药途径:TABLET;ORAL 规格:EQ 10MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021323 |
002 |
NDA |
LEXAPRO |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
Yes |
No |
AB |
2002/08/14
|
ABBVIE |
076765 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Discontinued |
No |
No |
AB |
2012/03/14
|
TEVA PHARMS USA |
077734 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
ZYDUS LIFESCIENCES |
078169 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
CHARTWELL RX |
078604 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
INVAGEN PHARMS |
078777 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
GRAVITI PHARMS |
090432 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
AUROBINDO PHARMA LTD |
090939 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
TORRENT PHARMS LTD |
202210 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
MACLEODS PHARMS LTD |
202389 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
ACCORD HLTHCARE |
202280 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2012/09/12
|
JUBILANT CADISTA |
077512 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Discontinued |
No |
No |
AB |
2012/09/12
|
ANIMA |
078032 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2015/08/28
|
PRINSTON INC |
205619 |
002 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2017/05/17
|
AMNEAL PHARMS |
活性成分:ESCITALOPRAM OXALATE 剂型/给药途径:TABLET;ORAL 规格:EQ 20MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021323 |
003 |
NDA |
LEXAPRO |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
Yes |
Yes |
AB |
2002/08/14
|
ABBVIE |
076765 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Discontinued |
No |
No |
AB |
2012/03/14
|
TEVA PHARMS USA |
077734 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
ZYDUS LIFESCIENCES |
078169 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
CHARTWELL RX |
078604 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
INVAGEN PHARMS |
078777 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
GRAVITI PHARMS |
090432 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
AUROBINDO PHARMA LTD |
090939 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
TORRENT PHARMS LTD |
202210 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
MACLEODS PHARMS LTD |
202389 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2012/09/11
|
ACCORD HLTHCARE |
202280 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2012/09/12
|
JUBILANT CADISTA |
077512 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Discontinued |
No |
No |
AB |
2012/09/12
|
ANIMA |
078032 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2015/08/28
|
PRINSTON INC |
205619 |
003 |
ANDA |
ESCITALOPRAM OXALATE |
ESCITALOPRAM OXALATE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2017/05/17
|
AMNEAL PHARMS |